Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (2)

Search Parameters:
Keywords = cannabinoids in endometriosis

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
19 pages, 2038 KB  
Article
Self-Reported Use and Effectiveness of Marijuana for Pelvic Pain Among Women with Endometriosis
by Anna E. Reinert, Maria Bolshakova, Alexander S. Wong and Victoria K. Cortessis
Reprod. Med. 2025, 6(3), 23; https://doi.org/10.3390/reprodmed6030023 - 8 Sep 2025
Viewed by 642
Abstract
Background/Objectives: Legal access to cannabinoids is increasing, and patients with chronic pelvic pain from endometriosis were hypothesized to explore and find benefit from the use of marijuana for symptom management. A survey of women with endometriosis was conducted with the objective of characterizing [...] Read more.
Background/Objectives: Legal access to cannabinoids is increasing, and patients with chronic pelvic pain from endometriosis were hypothesized to explore and find benefit from the use of marijuana for symptom management. A survey of women with endometriosis was conducted with the objective of characterizing their experience with marijuana for management of pelvic pain: exploring symptom benefit, characteristics of use, and factors contributing to use and discontinuation. Methods: A descriptive cross-sectional survey was undertaken using an anonymous online questionnaire. Participants were recruited from an outpatient gynecology clinic using endometriosis ICD-10 diagnostic codes, and from the Endometriosis Association mailing list. Results: Marijuana use for symptom relief was reported by 78 (32.2%) Endometriosis Association participants, and 58 (46.8%) clinic participants. Within both populations, marijuana was considered very or moderately effective by most users (68.0 to 75.9%). Legality of recreational and medicinal marijuana in the state of residence was strongly associated with use (OR 7.13 [95% CI: 2.57–19.8]). Among users specifying current or past use, discontinuation was reported by 45% (54 of 121), and most frequently attributed to non-clinical factors of legal/employment risk and obstacles to marijuana access; 64.8% of former users attributed discontinuation to non-clinical factors only. Lack of symptom relief from other clinical management was the most cited motivation for initiation (55.1% clinic, 39.7% EA users). Conclusions: Marijuana use is common among women with endometriosis and chronic, refractory pelvic pain. Legality and access appear to impact use and discontinuation. While legal access to marijuana is associated with increased use, marijuana obtained outside of legal routes is also commonly being used for symptom relief. Full article
Show Figures

Figure 1

20 pages, 371 KB  
Review
Endometriosis: A Comprehensive Analysis of the Pathophysiology, Treatment, and Nutritional Aspects, and Its Repercussions on the Quality of Life of Patients
by Gabriela Cano-Herrera, Sylvia Salmun Nehmad, Jimena Ruiz de Chávez Gascón, Amairani Méndez Vionet, Ximena A. van Tienhoven, María Fernanda Osorio Martínez, Mauricio Muleiro Alvarez, Mariana Ximena Vasco Rivero, María Fernanda López Torres, María Jimena Barroso Valverde, Isabel Noemi Torres, Alexa Cruz Olascoaga, Maria Fernanda Bautista Gonzalez, José Antonio Sarkis Nehme, Ignacio Vélez Rodríguez, Renata Murguiondo Pérez, Felipe Esparza Salazar, Ana Gabriela Sierra Bronzon, Eder Gabriel Rivera Rosas, Dante Carbajal Ocampo and Ramiro Cabrera Carrancoadd Show full author list remove Hide full author list
Biomedicines 2024, 12(7), 1476; https://doi.org/10.3390/biomedicines12071476 - 4 Jul 2024
Cited by 24 | Viewed by 19345
Abstract
Endometriosis is a chronic proinflammatory pathology characterized by the growth of tissue similar to the endometrium outside the uterus, affecting approximately 5 to 15% of women worldwide. Suffering from endometriosis entails a complex pathophysiological process, significantly impacting the quality of life and reproductive [...] Read more.
Endometriosis is a chronic proinflammatory pathology characterized by the growth of tissue similar to the endometrium outside the uterus, affecting approximately 5 to 15% of women worldwide. Suffering from endometriosis entails a complex pathophysiological process, significantly impacting the quality of life and reproductive function of affected women; therefore, it must be addressed in a personalized and comprehensive manner, as its management requires a multidisciplinary approach. This article aims to conduct a comprehensive literature review of endometriosis, not only as a pathophysiological condition but also as a significant factor impacting the social, nutritional, and mental well-being of those who experience it. Emphasis is placed on the importance of understanding and assessing the impact of the pathology to provide a better and more comprehensive approach, integrating various alternatives and strategic treatments for the factors involved in its development. The aim is to provide a complete overview of endometriosis, from its pathophysiology to its impact on the quality of life of patients, as well as a review of current treatment options, both pharmacological and alternative, in order to broaden the perspective on the pathology to improve the care of patients with this disease. Full article
(This article belongs to the Special Issue Advanced Research in Endometriosis 4.0)
Back to TopTop